Federal health officials will add warnings about potential blood-clot risks to fact sheets for health care providers and vaccine recipients.
Federal health officials called for a nationwide pause in use of the shot on April 13 after they received reports about six women between 18 and 48 who had developed the condition after vaccination. | AP Photo/David Zalubowski
By ERIN BANCO, SARAH OWERMOHLE and DAVID LIM
Federal health officials said late Friday that vaccinations with Johnson & Johnson’s coronavirus vaccine can restart, ending a 10-day pause over a potential link to rare and severe blood clots.
The Food and Drug Administration has amended the emergency use authorization for the vaccine to include mention of the clotting issue, and it will add warnings about the risk of the rare clots accompanied by low platelet counts to fact sheets for health care providers and vaccine recipients.
The Centers for Disease Control and Prevention is expected to release an analysis of the blood clot issue next week in its in-house journal, Morbidity and Mortality Weekly Report.